Logo image of QTRX

QUANTERIX CORP (QTRX) Stock Fundamental Analysis

NASDAQ:QTRX - Nasdaq - US74766Q1013 - Common Stock - Currency: USD

7.55  -0.03 (-0.4%)

After market: 7.45 -0.1 (-1.32%)

Fundamental Rating

4

QTRX gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 57 industry peers in the Life Sciences Tools & Services industry. No worries on liquidiy or solvency for QTRX as it has an excellent financial health rating, but there are worries on the profitability. QTRX is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

QTRX had negative earnings in the past year.
QTRX had a negative operating cash flow in the past year.
In the past 5 years QTRX always reported negative net income.
QTRX had a negative operating cash flow in each of the past 5 years.
QTRX Yearly Net Income VS EBIT VS OCF VS FCFQTRX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 -20M -40M -60M -80M

1.2 Ratios

QTRX has a Return On Assets (-12.28%) which is in line with its industry peers.
Looking at the Return On Equity, with a value of -14.89%, QTRX is in the better half of the industry, outperforming 63.16% of the companies in the same industry.
Industry RankSector Rank
ROA -12.28%
ROE -14.89%
ROIC N/A
ROA(3y)-13.48%
ROA(5y)-15.21%
ROE(3y)-16.07%
ROE(5y)-19.04%
ROIC(3y)N/A
ROIC(5y)N/A
QTRX Yearly ROA, ROE, ROICQTRX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1K 2K

1.3 Margins

The Gross Margin of QTRX (58.04%) is better than 77.19% of its industry peers.
In the last couple of years the Gross Margin of QTRX has grown nicely.
The Profit Margin and Operating Margin are not available for QTRX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 58.04%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.83%
GM growth 5Y4.96%
QTRX Yearly Profit, Operating, Gross MarginsQTRX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50 -50 -100 -150

More info and screens

7

2. Health

2.1 Basic Checks

QTRX does not have a ROIC to compare to the WACC, probably because it is not profitable.
QTRX has more shares outstanding than it did 1 year ago.
QTRX has more shares outstanding than it did 5 years ago.
QTRX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
QTRX Yearly Shares OutstandingQTRX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M
QTRX Yearly Total Debt VS Total AssetsQTRX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M 500M

2.2 Solvency

QTRX has an Altman-Z score of 1.68. This is a bad value and indicates that QTRX is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 1.68, QTRX perfoms like the industry average, outperforming 50.88% of the companies in the same industry.
There is no outstanding debt for QTRX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 1.68
ROIC/WACCN/A
WACC11.32%
QTRX Yearly LT Debt VS Equity VS FCFQTRX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M 200M 300M 400M

2.3 Liquidity

QTRX has a Current Ratio of 10.07. This indicates that QTRX is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 10.07, QTRX belongs to the best of the industry, outperforming 91.23% of the companies in the same industry.
QTRX has a Quick Ratio of 9.16. This indicates that QTRX is financially healthy and has no problem in meeting its short term obligations.
QTRX's Quick ratio of 9.16 is amongst the best of the industry. QTRX outperforms 89.47% of its industry peers.
Industry RankSector Rank
Current Ratio 10.07
Quick Ratio 9.16
QTRX Yearly Current Assets VS Current LiabilitesQTRX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M

More info and screens

5

3. Growth

3.1 Past

QTRX shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -2.91%.
Looking at the last year, QTRX shows a very strong growth in Revenue. The Revenue has grown by 42.21%.
The Revenue has been growing by 26.62% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-2.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-4.76%
Revenue 1Y (TTM)42.21%
Revenue growth 3Y12.3%
Revenue growth 5Y26.62%
Sales Q2Q%14.29%

3.2 Future

The Earnings Per Share is expected to decrease by -2.84% on average over the next years.
Based on estimates for the next years, QTRX will show a quite strong growth in Revenue. The Revenue will grow by 15.76% on average per year.
EPS Next Y-10.5%
EPS Next 2Y-3.78%
EPS Next 3Y4.94%
EPS Next 5Y-2.84%
Revenue Next Year13.21%
Revenue Next 2Y14%
Revenue Next 3Y15.32%
Revenue Next 5Y15.76%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
QTRX Yearly Revenue VS EstimatesQTRX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 100M 200M 300M
QTRX Yearly EPS VS EstimatesQTRX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 -0.5 -1 -1.5 -2 -2.5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

QTRX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year QTRX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
QTRX Price Earnings VS Forward Price EarningsQTRX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
QTRX Per share dataQTRX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-3.78%
EPS Next 3Y4.94%

More info and screens

0

5. Dividend

5.1 Amount

QTRX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

QUANTERIX CORP

NASDAQ:QTRX (2/21/2025, 8:00:01 PM)

After market: 7.45 -0.1 (-1.32%)

7.55

-0.03 (-0.4%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)11-12 2024-11-12/amc
Earnings (Next)03-17 2025-03-17/amc
Inst Owners96.04%
Inst Owner Change-92.88%
Ins Owners6.92%
Ins Owner Change2.31%
Market Cap291.20M
Analysts81.82
Price Target18.36 (143.18%)
Short Float %6.93%
Short Ratio3.32
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)10.03%
Min EPS beat(2)8.09%
Max EPS beat(2)11.96%
EPS beat(4)3
Avg EPS beat(4)9.35%
Min EPS beat(4)-1.74%
Max EPS beat(4)19.08%
EPS beat(8)6
Avg EPS beat(8)24.29%
EPS beat(12)8
Avg EPS beat(12)6.35%
EPS beat(16)11
Avg EPS beat(16)5.19%
Revenue beat(2)2
Avg Revenue beat(2)1.38%
Min Revenue beat(2)0.02%
Max Revenue beat(2)2.75%
Revenue beat(4)3
Avg Revenue beat(4)1.46%
Min Revenue beat(4)-0.58%
Max Revenue beat(4)3.65%
Revenue beat(8)6
Avg Revenue beat(8)5.33%
Revenue beat(12)9
Avg Revenue beat(12)2.75%
Revenue beat(16)13
Avg Revenue beat(16)5.29%
PT rev (1m)-8.7%
PT rev (3m)-11.27%
EPS NQ rev (1m)-1.39%
EPS NQ rev (3m)-26.41%
EPS NY rev (1m)2.1%
EPS NY rev (3m)4.2%
Revenue NQ rev (1m)-1.69%
Revenue NQ rev (3m)-12.04%
Revenue NY rev (1m)0.03%
Revenue NY rev (3m)0.29%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.76
P/FCF N/A
P/OCF N/A
P/B 0.86
P/tB 0.87
EV/EBITDA N/A
EPS(TTM)-1.06
EYN/A
EPS(NY)-0.93
Fwd EYN/A
FCF(TTM)-1.09
FCFYN/A
OCF(TTM)-0.96
OCFYN/A
SpS4.3
BVpS8.79
TBVpS8.66
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -12.28%
ROE -14.89%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 58.04%
FCFM N/A
ROA(3y)-13.48%
ROA(5y)-15.21%
ROE(3y)-16.07%
ROE(5y)-19.04%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.83%
GM growth 5Y4.96%
F-Score4
Asset Turnover0.4
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 81.94%
Cap/Sales 3.12%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 10.07
Quick Ratio 9.16
Altman-Z 1.68
F-Score4
WACC11.32%
ROIC/WACCN/A
Cap/Depr(3y)187.1%
Cap/Depr(5y)202.59%
Cap/Sales(3y)8.86%
Cap/Sales(5y)10.05%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-4.76%
EPS Next Y-10.5%
EPS Next 2Y-3.78%
EPS Next 3Y4.94%
EPS Next 5Y-2.84%
Revenue 1Y (TTM)42.21%
Revenue growth 3Y12.3%
Revenue growth 5Y26.62%
Sales Q2Q%14.29%
Revenue Next Year13.21%
Revenue Next 2Y14%
Revenue Next 3Y15.32%
Revenue Next 5Y15.76%
EBIT growth 1Y-49.54%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year8.71%
EBIT Next 3Y13.18%
EBIT Next 5Y18.35%
FCF growth 1Y37.34%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y32.36%
OCF growth 3YN/A
OCF growth 5YN/A